Rita J Desai

Array ( [id] => 7005820 [patent_doc_number] => 20050171133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 11/084410 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30408 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171133.pdf [firstpage_image] =>[orig_patent_app_number] => 11084410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138428 [patent_doc_number] => 20050182080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 11/082466 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30377 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182080.pdf [firstpage_image] =>[orig_patent_app_number] => 11082466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892273 [patent_doc_number] => 07345054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Heterocyclic inhibitors of ERK2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/077188 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17289 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345054.pdf [firstpage_image] =>[orig_patent_app_number] => 11077188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111650 [patent_doc_number] => 20050209106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Substituted 4-(4-trifluoromethylpyrazolyl)pyrimidines' [patent_app_type] => utility [patent_app_number] => 11/077110 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14272 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209106.pdf [firstpage_image] =>[orig_patent_app_number] => 11077110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111804 [patent_doc_number] => 20050209260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Diaminopyrimidines as P2X3 and P2X2/3 antagonists' [patent_app_type] => utility [patent_app_number] => 11/071555 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50381 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209260.pdf [firstpage_image] =>[orig_patent_app_number] => 11071555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823838 [patent_doc_number] => 07405310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Non-nucleoside reverse transcriptase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/071675 [patent_app_country] => US [patent_app_date] => 2005-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26082 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405310.pdf [firstpage_image] =>[orig_patent_app_number] => 11071675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5904606 [patent_doc_number] => 20060046987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Substituted quinazoline derivatives and their use as inhibitors' [patent_app_type] => utility [patent_app_number] => 11/070057 [patent_app_country] => US [patent_app_date] => 2005-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77616 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046987.pdf [firstpage_image] =>[orig_patent_app_number] => 11070057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307466 [patent_doc_number] => 07531532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Pyridine derivative and pyrimidine derivative' [patent_app_type] => utility [patent_app_number] => 11/065631 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 182542 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531532.pdf [firstpage_image] =>[orig_patent_app_number] => 11065631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322645 [patent_doc_number] => 07517878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Heteroarylaminopyrazole derivatives useful for the treatment of diabetes' [patent_app_type] => utility [patent_app_number] => 11/064700 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21435 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517878.pdf [firstpage_image] =>[orig_patent_app_number] => 11064700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945288 [patent_doc_number] => 20050197337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Aminomethylpyrimidines as allosteric enhancers of the GABAB receptors' [patent_app_type] => utility [patent_app_number] => 11/064046 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11123 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197337.pdf [firstpage_image] =>[orig_patent_app_number] => 11064046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887645 [patent_doc_number] => 20080261977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Pyrimidine Derivatives as Cannabinoid Receptor Modulators' [patent_app_type] => utility [patent_app_number] => 10/597521 [patent_app_country] => US [patent_app_date] => 2005-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24414 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261977.pdf [firstpage_image] =>[orig_patent_app_number] => 10597521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729772 [patent_doc_number] => 08101615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => '1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/590770 [patent_app_country] => US [patent_app_date] => 2005-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25874 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101615.pdf [firstpage_image] =>[orig_patent_app_number] => 10590770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 330548 [patent_doc_number] => 07511044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Vanilloid receptor ligands and their use in treatments' [patent_app_type] => utility [patent_app_number] => 11/056568 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28211 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/511/07511044.pdf [firstpage_image] =>[orig_patent_app_number] => 11056568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853211 [patent_doc_number] => 20080318954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 10/588372 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19423 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318954.pdf [firstpage_image] =>[orig_patent_app_number] => 10588372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005810 [patent_doc_number] => 20050171123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Quinazoline derivatives as medicaments' [patent_app_type] => utility [patent_app_number] => 11/053121 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9257 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171123.pdf [firstpage_image] =>[orig_patent_app_number] => 11053121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5080324 [patent_doc_number] => 20070123548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Pth agonists' [patent_app_type] => utility [patent_app_number] => 10/597858 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15616 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123548.pdf [firstpage_image] =>[orig_patent_app_number] => 10597858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177944 [patent_doc_number] => 07655652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation' [patent_app_type] => utility [patent_app_number] => 10/586954 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46972 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655652.pdf [firstpage_image] =>[orig_patent_app_number] => 10586954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602502 [patent_doc_number] => 07432265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Imidazopyrazines as cyclin dependent kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/047524 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12537 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432265.pdf [firstpage_image] =>[orig_patent_app_number] => 11047524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997436 [patent_doc_number] => 20050137214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => '2-(Pyridin-2-ylamino)-pyrido [2,3-D]pyrimidin-7-ones' [patent_app_type] => utility [patent_app_number] => 11/046126 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45411 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137214.pdf [firstpage_image] =>[orig_patent_app_number] => 11046126 [rel_patent_id] =>[rel_patent_doc_number] =>)